[ Price : $8.95]
FDA gives Cybrexa Therapeutics the green light to begin a clinical trial for solid tumor therapy CBX-12 (alphalex-exatecan).[ Price : $8.95]
FDA announces a 5/4 virtual public meeting entitled Patient-Generated Health Data Throughout the Total Product Life Cycle of Medic...[ Price : $8.95]
FDA accepts a Bristol Myers Squibb NDA for mavacamten, an investigational allosteric modulator of cardiac myosin for treating pati...[ Price : $8.95]
CBERs Office of Compliance and Biologics Quality sends Reno Integrative Medical Center an untitled letter after reviewing the inst...[ Price : $8.95]
An FDA safety alert advises that health care professionals not use Becton, Dickinsons ChloraPrep 3 mL applicators due to microbial...[ Price : $8.95]
Federal Register notice: HHS postpones, pending judicial review, the effective date of a final rule entitled Securing Updated and ...[ Price : $8.95]
FDA approves a Janssen NDA for Ponvory (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor modulator for tre...[ Price : $8.95]
FDA approves a Kiniksa Pharmaceuticals NDA for Arcalyst (rilonacept) injection to treat recurrent pericarditis in adults and child...